These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11483314)

  • 1. Cerebellar synaptic protein expression in schizophrenia.
    Eastwood SL; Cotter D; Harrison PJ
    Neuroscience; 2001; 105(1):219-29. PubMed ID: 11483314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.
    Eastwood SL; Harrison PJ
    Schizophr Res; 2005 Mar; 73(2-3):159-72. PubMed ID: 15653259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia.
    Harrison PJ; Eastwood SL
    Lancet; 1998 Nov; 352(9141):1669-73. PubMed ID: 9853440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain.
    Eastwood SL; Burnet PW; Harrison PJ
    Synapse; 2000 Jun; 36(3):167-77. PubMed ID: 10819897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.
    Eastwood SL; Harrison PJ
    Brain Res Bull; 2001 Jul; 55(5):569-78. PubMed ID: 11576753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology.
    Eastwood SL; Law AJ; Everall IP; Harrison PJ
    Mol Psychiatry; 2003 Feb; 8(2):148-55. PubMed ID: 12610647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.
    Sawada K; Barr AM; Nakamura M; Arima K; Young CE; Dwork AJ; Falkai P; Phillips AG; Honer WG
    Arch Gen Psychiatry; 2005 Mar; 62(3):263-72. PubMed ID: 15753239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs.
    Eastwood SL; Harrison PJ
    Mol Psychiatry; 2000 Jul; 5(4):425-32. PubMed ID: 10889554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice.
    Eastwood SL; Lyon L; George L; Andrieux A; Job D; Harrison PJ
    J Psychopharmacol; 2007 Aug; 21(6):635-44. PubMed ID: 17050659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics.
    Mukaetova-Ladinska E; Hurt J; Honer WG; Harrington CR; Wischik CM
    Neurosci Lett; 2002 Jan; 317(3):161-5. PubMed ID: 11755264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia.
    Burnet PW; Hutchinson L; von Hesling M; Gilbert EJ; Brandon NJ; Rutter AR; Hutson PH; Harrison PJ
    Schizophr Res; 2008 Jul; 102(1-3):283-94. PubMed ID: 18400471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes.
    Eastwood SL; Heffernan J; Harrison PJ
    Mol Psychiatry; 1997 Jul; 2(4):322-9. PubMed ID: 9246673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness.
    Sawada K; Young CE; Barr AM; Longworth K; Takahashi S; Arango V; Mann JJ; Dwork AJ; Falkai P; Phillips AG; Honer WG
    Mol Psychiatry; 2002; 7(5):484-92. PubMed ID: 12082566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics increase microtubule-associated protein 2 mRNA but not spinophilin mRNA in rat hippocampus and cortex.
    Law AJ; Hutchinson LJ; Burnet PW; Harrison PJ
    J Neurosci Res; 2004 May; 76(3):376-82. PubMed ID: 15079866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia.
    Eastwood SL; Burnet PW; Harrison PJ
    Biol Psychiatry; 2005 Apr; 57(7):702-10. PubMed ID: 15820226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia.
    Eastwood SL; Burnet PW; Harrison PJ
    Neuroscience; 1995 May; 66(2):309-19. PubMed ID: 7477874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.
    Karson CN; Mrak RE; Schluterman KO; Sturner WQ; Sheng JG; Griffin WS
    Mol Psychiatry; 1999 Jan; 4(1):39-45. PubMed ID: 10089007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.
    Egbujo CN; Sinclair D; Borgmann-Winter KE; Arnold SE; Turetsky BI; Hahn CG
    Schizophr Res; 2015 Oct; 168(1-2):554-62. PubMed ID: 26260078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of complexin I and complexin II in the medial thalamus is blocked by N-acetylcysteine in experimental Wernicke's encephalopathy.
    Hazell AS; Wang C
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):200-7. PubMed ID: 15573404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia.
    Webster MJ; Shannon Weickert C; Herman MM; Hyde TM; Kleinman JE
    Schizophr Res; 2001 Apr; 49(1-2):89-98. PubMed ID: 11343868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.